Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
As of close of business last night, Veracyte Inc’s stock clocked out at $30.25, down -7.27% from its previous closing price of $32.62. In other words, the price has decreased by -$7.27 from its previous closing price. On the day, 1.42 million shares were traded. VCYT stock price reached its highest trading level at $31.605 during the session, while it also had its lowest trading level at $28.74.
Ratios:
To gain a deeper understanding of VCYT’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 8.15 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 36.95. For the most recent quarter (mrq), Quick Ratio is recorded 4.46 and its Current Ratio is at 4.73. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Craig Hallum on March 20, 2025, initiated with a Buy rating and assigned the stock a target price of $45.
On December 05, 2024, Goldman Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $38 to $37.
On November 15, 2024, Wolfe Research started tracking the stock assigning a Outperform rating and target price of $50.Wolfe Research initiated its Outperform rating on November 15, 2024, with a $50 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 07 ’25 when Leite John sold 7,411 shares for $31.66 per share. The transaction valued at 234,630 led to the insider holds 100,249 shares of the business.
JOHN LEITE bought 7,411 shares of VCYT for $240,932 on Mar 07 ’25. On Mar 04 ’25, another insider, ANN MCGUIRE, who serves as the Officer of the company, bought 1,142 shares for $33.56 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VCYT now has a Market Capitalization of 2540999936 and an Enterprise Value of 2017797120. As of this moment, Veracyte’s Price-to-Earnings (P/E) ratio for their current fiscal year is 98.69, and their Forward P/E ratio for the next fiscal year is 43.57. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.33. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.29 while its Price-to-Book (P/B) ratio in mrq is 2.00. Its current Enterprise Value per Revenue stands at 4.527 whereas that against EBITDA is 40.166.
Stock Price History:
The Beta on a monthly basis for VCYT is 2.11, which has changed by 0.495304 over the last 52 weeks, in comparison to a change of 0.028231144 over the same period for the S&P500. Over the past 52 weeks, VCYT has reached a high of $47.32, while it has fallen to a 52-week low of $18.61. The 50-Day Moving Average of the stock is -14.01%, while the 200-Day Moving Average is calculated to be -11.52%.
Shares Statistics:
It appears that VCYT traded 980.72K shares on average per day over the past three months and 1169990 shares per day over the past ten days. A total of 77.77M shares are outstanding, with a floating share count of 76.84M. Insiders hold about 1.42% of the company’s shares, while institutions hold 102.80% stake in the company. Shares short for VCYT as of 1741910400 were 3302156 with a Short Ratio of 4.25, compared to 1739491200 on 3131797. Therefore, it implies a Short% of Shares Outstanding of 3302156 and a Short% of Float of 4.7199998.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
